Cargando…

DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is one of the major causes of tumor-related morbidity and mortality worldwide. Accumulating evidence has revealed that aberrant expression of crucial cancer-related genes contributes to hepatocellular carcinogenesis. This study aimed to characterize the bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chao, Wang, Pu, Tu, Mengtian, Huang, Yi, Xiong, Fei, Wu, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620382/ https://www.ncbi.nlm.nih.gov/pubmed/31189746 http://dx.doi.org/10.1042/BSR20190946

Ejemplares similares

Long Non-Coding RNA PART1 Promotes Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells via miR-149-5p/MAP2K1 Axis
por: Zhou, Chao, et al.
Publicado: (2020)

Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
por: Dang, Xiao-Wei, et al.
Publicado: (2021)

Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
por: Fan, Xiaoyan, et al.
Publicado: (2022)

Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
por: Tian, Chuan, et al.
Publicado: (2021)

DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway
por: Guo, Wubin, et al.
Publicado: (2019)

Correction to: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
por: Tian, Chuan, et al.
Publicado: (2021)

DEPDC7 inhibits cell proliferation, migration and invasion in hepatoma cells
por: Liao, Zhijun, et al.
Publicado: (2017)

Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway
por: Xu, Lin, et al.
Publicado: (2021)

Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy
por: Motomura, Takashi, et al.
Publicado: (2012)

DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma
por: Mizuno, Yuki, et al.
Publicado: (2018)

Artemisia argyi Essential Oil Inhibits Hepatocellular Carcinoma Metastasis via Suppression of DEPDC1 Dependent Wnt/β-Catenin Signaling Pathway
por: Li, Yanli, et al.
Publicado: (2021)

DEPDC1B is a key regulator of myoblast proliferation in mouse and man
por: Figeac, Nicolas, et al.
Publicado: (2019)

Silencing eL31 suppresses the progression of colorectal cancer via targeting DEPDC1
por: Sharen, Gaowa, et al.
Publicado: (2022)

DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma
por: Feng, Xuefei, et al.
Publicado: (2017)

Correlation of DEPDC5 rs1012068 and rs5998152 Polymorphisms with Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhu, Shaoliang, et al.
Publicado: (2023)

Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma
por: Hai, Hoang, et al.
Publicado: (2017)

DEPDC1B is involved in the proliferation, metastasis, cell cycle arrest and apoptosis of colon cancer cells by regulating NUP37
por: Xiong, Hui, et al.
Publicado: (2023)

KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma
por: Sun, Yue-Feng, et al.
Publicado: (2020)

High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma
por: Li, Pulin, et al.
Publicado: (2022)

Knockdown of DEPDC1B inhibits the development of glioblastoma
por: Chen, Xu, et al.
Publicado: (2020)

Getting Sucker Punched by Depdc5 Really Hurts
por: Weston, Matthew
Publicado: (2020)

DEPDC1 as a crucial factor in the progression of human osteosarcoma
por: Shen, Lin, et al.
Publicado: (2022)

Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6
por: He, Ao-Di, et al.
Publicado: (2017)

The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling
por: Li, Zean, et al.
Publicado: (2020)

FOXM1 is regulated by DEPDC1 to facilitate development and metastasis of oral squamous cell carcinoma
por: Qiu, Jing, et al.
Publicado: (2022)

Epileptic spasms are a feature of DEPDC5 mTORopathy
por: Carvill, Gemma L., et al.
Publicado: (2015)

Partial deletion of DEPDC5 in a child with focal epilepsy
por: Bonaglia, Maria Clara, et al.
Publicado: (2016)

DEPDC1B collaborates with GABRD to regulate ESCC progression
por: Yuan, Yunfeng, et al.
Publicado: (2022)

MiR-27a Promotes Hepatocellular Carcinoma Cell Proliferation Through Suppression of its Target Gene Peroxisome Proliferator-activated Receptor γ
por: Li, Shuo, et al.
Publicado: (2015)

Id4 promotes cell proliferation in hepatocellular carcinoma
por: Zhang, Yang, et al.
Publicado: (2017)

What is the impact of a novel DEPDC5 variant on an infant with focal epilepsy: a case report
por: Gu, Chunyu, et al.
Publicado: (2022)

Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
por: Xu, Jianliang, et al.
Publicado: (2019)

Cardiac Investigations in Sudden Unexpected Death in DEPDC5 ‐Related Epilepsy
por: Bacq, Alexandre, et al.
Publicado: (2021)

KIFC1 promotes the proliferation of hepatocellular carcinoma in vitro and in vivo
por: Wang, Xing, et al.
Publicado: (2019)

DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1
por: Lai, Chin-Hui, et al.
Publicado: (2020)

DEPDC1B promotes development of cholangiocarcinoma through enhancing the stability of CDK1 and regulating malignant phenotypes
por: Zhang, Zhenhai, et al.
Publicado: (2022)

DEPDC1 is a novel cell cycle related gene that regulates mitotic progression
por: Mi, Yan, et al.
Publicado: (2015)

S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy
por: Qi, Mengxin, et al.
Publicado: (2023)

AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
por: Meng, Yue, et al.
Publicado: (2018)

High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
por: Zhao, Huishan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hmkhhbt8147jorh3ak5p9ar7q0